Vascular disrupting agent arsenic trioxide enhances thermoradiotherapy of solid tumors

Journal of Oncology

Volumn , Issue , 2012, Pages

  Griffin, Robert J ^a   Williams, Brent W ^b   Koonce, Nathan A ^a   Bischof, John C ^b   Song, Chang W ^b   Asur, Rajalakshmi ^a   Upreti, Meenakshi ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; FIBROSARCOMA; HYPERTHERMIC THERAPY; IN VIVO STUDY; MOUSE; NONHUMAN; THERMORADIOTHERAPY; TUMOR NECROSIS;

EID: 84856489572     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/934918     Document Type: Article

References (38)

1. Fang J., Chen S. J., Tong J. H., Wang Z. G., Chen G. Q., Chen Z., Treatment of acute promyelocytic leukemia with ATRA and As2O3: a model of molecular target-based cancer therapy Cancer Biology Therapy 2002 1 6 614 620
2. Cai X., Yu Y., Huang Y., Zhang L., Jia P. M., Zhao Q., Chen Z., Tong J. H., Dai W., Chen G. Q., Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells Leukemia 2003 17 7 1333 1337 (Pubitemid 36857340)
3. Evens A. M., Tallman M. S., Gartenhaus R. B., The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future Leukemia Research 2004 28 9 891 900 (Pubitemid 38953641)
4. Miller W. H. Jr., Schipper H. M., Lee J. S., Singer J., Waxman S., Mechanisms of action of arsenic trioxide Cancer Research 2002 62 14 3893 3903 (Pubitemid 34792653)
5. Miller W. H. Jr., Molecular targets of arsenic trioxide in malignant cells Oncologist 2002 7 supplement 1 14 19
6. Soignet S. L., Maslak P., Wang Z. G., Jhanwar S., Calleja E., Dardashti L. J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D. A., Pandolfi P. P., Warrell R. P., Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide The New England Journal of Medicine 1998 339 19 1341 1348 (Pubitemid 28509343)
7. Lew Y. S., Brown S. L., Griffin R. J., Song C. W., Kim J. H., Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown Cancer Research 1999 59 24 6033 6037 (Pubitemid 30035615)
8. Griffin R. J., Lee S. H., Rood K. L., Stewart M. J., Lyons J. C., Lew Y. S., Park H., Song C. W., Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors Neoplasia 2000 2 6 555 560 (Pubitemid 32098690)
9. Griffin R. J., Monzen H., Williams B. W., Park H., Lee S. H., Song C. W., Arsenic trioxide induces selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumours International Journal of Hyperthermia 2003 19 6 575 589 (Pubitemid 37406668)
10. Griffin R. J., Williams B. W., Park H. J., Song C. W., Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy International Journal of Radiation Oncology Biology Physics 2005 61 5 1516 1522 (Pubitemid 40470436)
11. Kim J. H., Lew Y. S., Kolozsvary A., Ryu S., Brown S. L., Arsenic trioxide enhances radiation response of 9L glioma in the rat brain Radiation Research 2003 160 6 662 666 (Pubitemid 37521709)
12. Lew Y. S., Kolozsvary A., Brown S. L., Kim J. H., Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor Cancer Research 2002 62 15 4202 4205 (Pubitemid 34827272)
13. Ahn R. W., Chen F., Chen H., Stern S. T., Clogston J. D., Patri A. K., Raja M. R., Swindell E. P., Parimi V., Cryns V. L., O'Halloran T. V., A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer Clinical Cancer Research 2010 16 14 3607 3617
14. Chen H., Ahn R., van den Bossche J., Thompson D. H., O'Halloran T. V., Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide Molecular Cancer Therapeutics 2009 8 7 1955 1963
15. Monzen H., Griffin R. J., Williams B. W., Amano M., Ando S., Hasegawa T., Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor Radiation Medicine 2004 22 4 205 211 (Pubitemid 39264796)
16. Westermann A. M., Jones E. L., Schem B. C., van der Steen-Banasik E. M., Koper P., Mella O., Uitterhoeve A. L. J., de Wit R., Van Der Velden J., Burger C., Van Der Wilt C. L., Dahl O., Prosnitz L. R., Van Der Zee J., First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma Cancer 2005 104 4 763 770 (Pubitemid 41113675)
17. Bergs J. W. J., Franken N. A. P., Haveman J., Geijsen E. D., Crezee J., van Bree C., Hyperthermia, cisplatin and radiation trimodality treatment: a promising cancer treatment? A review from preclinical studies to clinical application International Journal of Hyperthermia 2007 23 4 329 341 (Pubitemid 46930177)
18. Hoffmann N. E., Bischof J. C., Cryosurgery of normal and tumor tissue in the dorsal skin flap chamber: part Ithermal response Journal of Biomechanical Engineering 2001 123 4 301 309 (Pubitemid 32830375)
19. Kalambur V. S., Mahaseth H., Bischof J. C., Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy American Journal of Hematology 2004 77 2 117 125 (Pubitemid 39281854)
20. Bhowmick S., Hoffmann N. E., Bischof J. C., Thermal therapy of prostate tumor tissue in the dorsal skin flap chamber Microvascular Research 2002 64 1 170 173 (Pubitemid 34713243)
21. Griffin R. J., Williams B. W., Bischof J. C., Olin M., Johnson G. L., Lee B. W., Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapy Technology in Cancer Research and Treatment 2007 6 6 651 654
22. Bernier J., Denekamp J., Rojas A., Trov M., Horiot J. C., Hamers H., Antognoni P., Dahl O., Richaud P., Kaanders J., van Glabbeke M., Piérart M., ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC Radiotherapy and Oncology 1999 52 2 149 156 (Pubitemid 29461082)
23. Dewey W. C., Interaction of heat with radiation and chemotherapy Cancer Research 1984 44 10 4714s 4720s (Pubitemid 14000087)
24. Horsman M. R., Chaplin D. J., Overgaard J., Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells Cancer Research 1990 50 23 7430 7436
25. Bischof M., Abdollahi A., Gong P., Stoffregen C., Lipson K. E., Debus J., Weber K. J., Huber P. E., Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells International Journal of Radiation Oncology Biology Physics 2004 60 4 1220 1232 (Pubitemid 39440809)
26. Herman T. S., Teicher B. A., Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma Cancer Research 1988 48 10 2693 2697
27. Herman T. S., Teicher B. A., Coleman C. N., Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo Cancer Research 1990 50 16 5055 5059 (Pubitemid 20257935)
28. Horsman M. R., Murata R., Combination of vascular targeting agents with thermal or radiation therapy International Journal of Radiation Oncology Biology Physics 2002 54 5 1518 1523 (Pubitemid 35380058)
29. Horsman M. R., Murata R., Overgaard J., Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation Acta Oncologica 2001 40 4 497 503 (Pubitemid 32682034)
30. Murata R., Horsman M. R., Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid International Journal of Hyperthermia 2004 20 4 393 404 (Pubitemid 38832569)
31. Herman T. S., Jochelson M. S., Teicher B. A., Scott P. J., Hansen J., Clark J. R., Pfeffer M. R., Gelwan L. E., Molnar-Griffin B. J., Fraser S. M., Svensson G., Bornstein B. A., Ryan L., Coleman C. N., A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies International Journal of Radiation Oncology Biology Physics 1989 17 6 1273 1279 (Pubitemid 20028646)
32. Herman T. S., Teicher B. A., Holden S. A., Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C International Journal of Radiation Oncology Biology Physics 1990 18 2 375 382 (Pubitemid 20097533)
33. Huber P. E., Bischof M., Jenne J., Heiland S., Peschke P., Saffrich R., Grne H. J., Debus J., Lipson K. E., Abdollahi A., Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy Cancer Research 2005 65 9 3643 3655 (Pubitemid 40616341)
34. Hokland S. L., Horsman M. R., The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization International Journal of Hyperthermia 2007 23 7 599 606 (Pubitemid 350187055)
35. Murata R., Overgaard J., Horsman M. R., Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotheraphy International Journal of Radiation Oncology Biology Physics 2001 51 4 1018 1024 (Pubitemid 33026433)
36. Hines-Peralta A., Sukhatme V., Regan M., Signoretti S., Liu Z. J., Goldberg S. N., Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models Radiology 2006 240 1 82 89 (Pubitemid 43902597)
37. Dilda P. J., Decollogne S., Weerakoon L., Norris M. D., Haber M., Allen J. D., Hogg P. J., Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosol Journal of Medicinal Chemistry 2009 52 20 6209 6216
38. Dilda P. J., Hogg P. J., Arsenical-based cancer drugs Cancer Treatment Reviews 2007 33 6 542 564 (Pubitemid 47355338)